Efficacy and safety of canagliflozin in type 2 diabetes mellitus: systematic review of randomized controlled trials.
BACKGROUND: Currently available antihyperglycemic agents (AHAs), despite being effective, do not provide adequate glycemic control in some cases and are associated with side effects. A sodium glucose co-transporter 2 inhibitor, canagliflozin, is a newer A..... Read More